Skip to main content

Table 5 Characteristics of patients with stable disease

From: Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

Nb of patients

Age (YEARS)

Sex

Previous lines of chemotherapy

DL

Type of cancer

Duration of stable disease (MONTHS)

Global survival (MONTHS)

Patient 9

60

Male

11

3

rectum

1

6

Patient 12

62

Male

3

4

colon

9

19

Patient 17

57

Male

4

8

lung

2

12